Researchers from Queen Mary University of London have identified the protein which the team say may be a specific diagnostic biomarker for pancreatic cancer, with the ability to differentiate pancreatic cancer from other non-cancerous conditions of the pancreas.
The research was published in npj Precision Oncology, and funded by the Pancreatic Cancer Research Fund, Barts Charity, and Cancer Research UK. Read more . . .